Potential impact of curative and preventive interventions toward hepatitis C elimination in people who inject drugs–A network modeling study
Open Access
- 20 July 2024
- journal article
- research article
- Published by Elsevier in International Journal of Drug Policy
- Vol. 130, 104539
Abstract
No abstract availableKeywords
Funding Information
- National Institute on Drug Abuse
- Massachusetts Department of Public Health
- National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention
This publication has 49 references indexed in Scilit:
- Changing Urban–Rural Disparities in the Utilization of Direct-Acting Antiviral Agents for Hepatitis C in U.S. Medicare Patients, 2014–2017American Journal of Preventive Medicine, 2021
- Harm Reduction Coverage and Hepatitis C Incidence: Findings From a Cohort of People Who Inject DrugsAmerican Journal of Preventive Medicine, 2020
- Network-Based Research on Rural Opioid Use: an Overview of Methods and Lessons LearnedCurrent HIV/AIDS Reports, 2018
- Hepatitis C transmission and treatment as prevention – The role of the injecting networkInternational Journal of Drug Policy, 2015
- The cost-effectiveness of harm reductionInternational Journal of Drug Policy, 2015
- The impact of injecting networks on hepatitis C transmission and treatment in people who inject drugsHepatology, 2014
- Effectiveness of Structural-Level Needle/Syringe Programs to Reduce HCV and HIV Infection Among People Who Inject Drugs: A Systematic ReviewAIDS and Behavior, 2013
- Hepatitis C viremia and genotype distribution among a sample of nonmedical prescription drug users exposed to HCV in rural AppalachiaJournal of Medical Virology, 2012
- Individual and network factors associated with non-fatal overdose among rural Appalachian drug usersDrug and Alcohol Dependence, 2011
- Utilization patterns and correlates of retention among clients of the needle exchange program in Baltimore, MarylandDrug and Alcohol Dependence, 2009